Wells Fargo has recently initiated Revvity Inc (RVTY) stock to Equal Weight rating, as announced on August 28, 2024, according to Finviz. Earlier, on July 8, 2024, Leerink Partners had initiated the stock to Outperform, setting a price target of $125. Jefferies also resumed Hold rating with a price target of $115. Additionally, UBS reduced Neutral rating on January 16, 2024, with a target price of $125. Evercore ISI analysts, in their report published on January 4, 2024, also raised their rating and set a price target of $88 for Revvity Inc’s stock. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment.
Revvity Inc (RVTY) Stock Trading Recap
On Tuesday, Revvity Inc (RVTY) stock saw a decline, ending the day at $119.74 which represents a decrease of $-2.80 or -2.28% from the prior close of $122.54. The stock opened at $121.51 and touched a low of $118.94 during the day, reaching a high of $122.81. The volume of shares traded was 0.54 million falling short of the average volume of 0.83 million.
Sponsored
RVTY Stock Performance and Moving Averages
In recent trading, Revvity Inc (RVTY) stock price has shown some volatility, fluctuating -1.19% over the last five trades and -2.86% over the past 30 trades. This represents a notable shift from earlier in the year. Over the last six months, the stock has risen by 10.35%, and it has gained 10.06% in the previous three months. Currently, RVTY is trading at -0.16%, 4.70%, and 12.33% relative to its 20-Day, 50-Day, and 200-Day Simple Moving Averages, respectively.
As of the latest trading close, RVTY, a Healthcare sector stock, is trading -6.56% below its 52-week high but remains 50.62% above its 52-week low. The Average True Range (ATR) (14 days) of 2.83 highlights the stock’s average volatility, providing insight into how much the price typically fluctuates. This measure is crucial for understanding potential price swings and assessing overall market risk.
Revvity Inc’s Profitability and Valuation Ratios
Revvity Inc’s profitability metrics reveal strong financial health. The company currently boasts an operating margin of 13.60% and a profit margin of 8.09%, with a gross margin of 10.35%. The profit margin, also known as the revenue ratio or gross profit ratio, measures how efficiently a company converts sales into net income; higher margins indicate greater profitability.
In terms of valuation, Revvity Inc’s market capitalization stands at $14.77 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value. The stock’s price-to-earnings (P/E) ratio is 67.49, assessing the company’s valuation relative to its earnings. The forward P/E ratio, which uses projected earnings for the next financial year, is 23.07. Additionally, the Price-to-Sales Ratio is 5.45, reflecting the market’s valuation of the company’s sales, while the Price-to-Book Ratio is 1.88, comparing the market value to the company’s book value.
Understanding Insider Trading
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.40% of Revvity Inc (RVTY)’s shares, while financial institutions hold 91.51%.
Notable insider trades include MICHAS ALEXIS P, Director at Revvity Inc (RVTY), who sold 850 shares on Aug 15 ’24, at $118.62 each, totaling $0.10 million. On Aug 07 ’24, Goldberg Joel S, Please See Remarks, sold 3500 shares for $117.86 each, amounting to $0.41 million. Additionally, on Jun 07 ’24, Goldberg Joel S sold 4000 shares at $110.46 each, generating $0.44 million.
